We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Issues Guidance on Special Access to Experimental Drugs
Canada Issues Guidance on Special Access to Experimental Drugs
February 15, 2007
Health Canada has released draft guidance for manufacturers and healthcare professionals detailing procedures under the special access program (SAP) for drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor